(NBIS) Nebius - Overview
Stock: AI Infrastructure, Data Labeling, Education Platform, Autonomous Driving
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 104% |
| Relative Tail Risk | -5.90% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.32 |
| Alpha | 120.11 |
| Character TTM | |
|---|---|
| Beta | 2.559 |
| Beta Downside | 2.540 |
| Drawdowns 3y | |
|---|---|
| Max DD | 80.15% |
| CAGR/Max DD | 0.13 |
Description: NBIS Nebius December 17, 2025
Nebius Group N.V. (NASDAQ: NBIS) is a Netherlands-based technology firm that designs and operates full-stack AI infrastructure across Europe, North America, and Israel, offering large-scale GPU clusters, cloud platforms, and developer tooling.
Its product portfolio includes:
• **Nebius** – end-to-end AI compute and cloud services;
• **Toloka** – a crowdsourced data-labeling platform used for training generative-AI models;
• **TripleTen** – an ed-tech solution that reskills workers for technology-focused careers;
• **Avride** – autonomous-driving software for self-driving cars and delivery robots.
The company, originally incorporated as Yandex N.V. in 1989, rebranded to Nebius Group N.V. in August 2024 and remains headquartered in Amsterdam.
Key market drivers that shape Nebius’s growth prospects include:
• The global AI-infrastructure market is projected to expand at a CAGR of ~30 % through 2029, fueled by surging demand for GPU compute.
• Data-annotation services now represent a $7 bn market, with enterprises increasingly outsourcing labeling to platforms like Toloka.
• The autonomous-driving sector is expected to reach $200 bn in annual revenue by 2030, creating a long-run addressable market for Avride’s technology.
Assuming Nebius can capture even 0.5 % of the AI-infrastructure spend, its revenue runway could exceed $150 m within three years, though current disclosed financials remain limited.
For a deeper, data-driven assessment of NBIS’s valuation and risk profile, you may find the analytics on ValueRay worth exploring.
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income: 218.6m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.20 > 0.02 and ΔFCF/TA -27.29 > 1.0 |
| NWC/Revenue: 1285 % < 20% (prev 3115 %; Δ -1831 % < -1%) |
| CFO/TA -0.02 > 3% & CFO -229.8m > Net Income 218.6m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 6.57 > 1.5 & < 3 |
| Outstanding Shares: last quarter (251.8m) vs 12m ago -12.26% < -2% |
| Gross Margin: 62.27% > 18% (prev 0.43%; Δ 6184 % > 0.5%) |
| Asset Turnover: 5.25% > 50% (prev 2.43%; Δ 2.82% > 0%) |
| Interest Coverage Ratio: -5.50 > 6 (EBITDA TTM -338.3m / Interest Expense TTM 92.6m) |
Altman Z'' 4.21
| A: 0.44 (Total Current Assets 5.22b - Total Current Liabilities 794.6m) / Total Assets 10.10b |
| B: 0.35 (Retained Earnings 3.57b / Total Assets 10.10b) |
| C: -0.08 (EBIT TTM -509.2m / Avg Total Assets 6.55b) |
| D: 0.68 (Book Value of Equity 3.58b / Total Liabilities 5.29b) |
| Altman-Z'' Score: 4.21 = AA |
Beneish M 0.41
| DSRI: 0.96 (Receivables 237.1m/52.2m, Revenue 344.2m/73.0m) |
| GMI: 0.70 (GM 62.27% / 43.44%) |
| AQI: 2.74 (AQ_t 0.11 / AQ_t-1 0.04) |
| SGI: 4.71 (Revenue 344.2m / 73.0m) |
| TATA: 0.04 (NI 218.6m - CFO -229.8m) / TA 10.10b) |
| Beneish M-Score: 0.41 (Cap -4..+1) = D |
What is the price of NBIS shares?
Over the past week, the price has changed by +1.07%, over one month by -14.11%, over three months by -21.33% and over the past year by +149.20%.
Is NBIS a buy, sell or hold?
- StrongBuy: 2
- Buy: 1
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the NBIS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 151.5 | 76% |
| Analysts Target Price | 151.5 | 76% |
| ValueRay Target Price | 93.9 | 9% |
NBIS Fundamental Data Overview February 03, 2026
P/S = 59.0461
P/B = 4.9678
Revenue TTM = 344.2m USD
EBIT TTM = -509.2m USD
EBITDA TTM = -338.3m USD
Long Term Debt = 4.09b USD (from longTermDebt, last quarter)
Short Term Debt = 72.8m USD (from shortTermDebt, last quarter)
Debt = 4.57b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -225.8m USD (from netDebt column, last quarter)
Enterprise Value = 21.23b USD (21.45b + Debt 4.57b - CCE 4.79b)
Interest Coverage Ratio = -5.50 (Ebit TTM -509.2m / Interest Expense TTM 92.6m)
EV/FCF = -10.51x (Enterprise Value 21.23b / FCF TTM -2.02b)
FCF Yield = -9.52% (FCF TTM -2.02b / Enterprise Value 21.23b)
FCF Margin = -587.0% (FCF TTM -2.02b / Revenue TTM 344.2m)
Net Margin = 63.51% (Net Income TTM 218.6m / Revenue TTM 344.2m)
Gross Margin = 62.27% ((Revenue TTM 344.2m - Cost of Revenue TTM 129.9m) / Revenue TTM)
Gross Margin QoQ = 70.64% (prev 71.36%)
Tobins Q-Ratio = 2.10 (Enterprise Value 21.23b / Total Assets 10.10b)
Interest Expense / Debt = 0.32% (Interest Expense 14.7m / Debt 4.57b)
Taxrate = 21.0% (US default 21%)
NOPAT = -402.3m (EBIT -509.2m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 6.57 (Total Current Assets 5.22b / Total Current Liabilities 794.6m)
Debt / Equity = 0.95 (Debt 4.57b / totalStockholderEquity, last quarter 4.81b)
Debt / EBITDA = 0.67 (negative EBITDA) (Net Debt -225.8m / EBITDA -338.3m)
Debt / FCF = 0.11 (negative FCF - burning cash) (Net Debt -225.8m / FCF TTM -2.02b)
Total Stockholder Equity = 3.75b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.34% (Net Income 218.6m / Total Assets 10.10b)
RoE = 5.83% (Net Income TTM 218.6m / Total Stockholder Equity 3.75b)
RoCE = -6.49% (EBIT -509.2m / Capital Employed (Equity 3.75b + L.T.Debt 4.09b))
RoIC = -8.00% (negative operating profit) (NOPAT -402.3m / Invested Capital 5.03b)
WACC = 12.70% (E(21.45b)/V(26.02b) * Re(15.35%) + D(4.57b)/V(26.02b) * Rd(0.32%) * (1-Tc(0.21)))
Discount Rate = 15.35% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -16.54%
Fair Price DCF = unknown (Cash Flow -2.02b)
EPS Correlation: -28.27 | EPS CAGR: 35.71% | SUE: 4.0 | # QB: 1
Revenue Correlation: -30.56 | Revenue CAGR: -46.01% | SUE: N/A | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.06 | Chg30d=+0.185 | Revisions Net=+1 | Analysts=2
EPS next Year (2026-12-31): EPS=-2.77 | Chg30d=+0.000 | Revisions Net=+1 | Growth EPS=-422.6% | Growth Revenue=+521.1%